These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 3621943

  • 21. Pharmacokinetics of norethisterone oenanthate in humans.
    Sang GW, Fotherby K, Howard G, Elder M, Bye PG.
    Contraception; 1981 Jul; 24(1):15-27. PubMed ID: 7273765
    [Abstract] [Full Text] [Related]

  • 22. Bioavailability and pharmacokinetics of norethisterone in women after oral doses of ethynodiol diacetate.
    Vose CW, Butler JK, Williams BM, Stafford JE, Shelton JR, Rose DA, Palmer RF, Breckenridge AM, Orme ML, Serlin MJ.
    Contraception; 1979 Feb; 19(2):119-27. PubMed ID: 428229
    [Abstract] [Full Text] [Related]

  • 23. Single and multiple administration of a new triphasic oral contraceptive to women: pharmacokinetics of ethinyl estradiol and free and total testosterone levels in serum.
    Kuhnz W, Sostarek D, Gansau C, Louton T, Mahler M.
    Am J Obstet Gynecol; 1991 Sep; 165(3):596-602. PubMed ID: 1892184
    [Abstract] [Full Text] [Related]

  • 24. Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
    Joshi UM, Joshi JV, Donde UM, Sankoli GM, Virkar KD, Saxena BN.
    Contraception; 1985 Jan; 31(1):71-82. PubMed ID: 3921309
    [Abstract] [Full Text] [Related]

  • 25. Influence of nutritional status on pharmacokinetics of contraceptive progestogens.
    Nutr Rev; 1984 May; 42(5):182-3. PubMed ID: 6377130
    [Abstract] [Full Text] [Related]

  • 26. Comparative pharmacokinetics of two new steroidal estrogens and ethinylestradiol in postmenopausal women.
    Baumann A, Fuhrmeister A, Brudny-Klöppel M, Draeger C, Bunte T, Kuhnz W.
    Contraception; 1996 Oct; 54(4):235-42. PubMed ID: 8922877
    [Abstract] [Full Text] [Related]

  • 27. Plasma levels and pharmacokinetics of norethindrone and ethinylestradiol administered in solution and as tablets to women.
    Stanczyk FZ, Mroszczak EJ, Ling T, Runkel R, Henzl M, Miyakawa I, Goebelsmann U.
    Contraception; 1983 Sep; 28(3):241-51. PubMed ID: 6641224
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W, Assendorp R, Kloosterboer L, van Lier W, Voortman G, Qvist I.
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [Abstract] [Full Text] [Related]

  • 31. Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin.
    Song S, Chen JK, He ML, Fotherby K.
    Contraception; 1989 Apr; 39(4):385-99. PubMed ID: 2498034
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
    Kuhnz W, al-Yacoub G, Fuhrmeister A.
    Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
    [Abstract] [Full Text] [Related]

  • 33. Subdermal norethindrone pellets -- a method for contraception?
    Odlind V, Moo-Young AJ, Gupta GN, Weiner E, Johansson ED.
    Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
    [Abstract] [Full Text] [Related]

  • 34. Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
    Wild RA, Demers LM, Applebaum-Bowden D, Lenker R.
    Contraception; 1991 Aug; 44(2):113-24. PubMed ID: 1893706
    [Abstract] [Full Text] [Related]

  • 35. Liver function tests in patients on oral progestogens.
    Engineer AD, Gupta V, Tandon P.
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [Abstract] [Full Text] [Related]

  • 36. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Apr; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 37. Control of fertility with oral medication.
    Diddle AW, Watts GF, Gardner WH, Williamson PJ.
    West J Surg Obstet Gynecol; 1964 Apr; 72():222-9. PubMed ID: 12305556
    [Abstract] [Full Text] [Related]

  • 38. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
    Jung-Hoffmann C, Fitzner M, Kuhl H.
    Horm Res; 1991 Apr; 36(5-6):238-46. PubMed ID: 1823082
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of norethindrone in Indian Women.
    Prasad KV, Rao BS, Sivakumar B, Prema K.
    Contraception; 1979 Jul; 20(1):77-90. PubMed ID: 477319
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.